إعلان
إعلان
MBX
MBX Biosciences, Inc. Common Stock
31.69
USDبرعاية
+0.97
+3.15%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
31.80
+0.11
+0.36%
تقارير أرباح MBX
النسبة الإيجابية المفاجئة
MBX تفوق 4 من 5 آخر التقديرات.
80%
التقرير التالي
بيانات التقرير القادم
١٧ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.66
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+4.76%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/+40.43%
MBX Biosciences, Inc. Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, MBX reported earnings of -0.63 USD per share (EPS) for Q3 25, beating the estimate of -0.70 USD, resulting in a 10.09% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +9.71% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 المحللين forecast an EPS of -0.66 USD, with revenue projected to reach -- USD, implying an زيادة of 4.76% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were MBX Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, MBX Biosciences, Inc. Common Stock reported EPS of -$0.63, beating estimates by 10.09%, and revenue of $0.00, 0% as expectations.
How did the market react to MBX Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 9.71%, changed from $22.55 before the earnings release to $24.74 the day after.
When is MBX Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٧ مارس ٢٠٢٦.
What are the forecasts for MBX Biosciences, Inc. Common Stock's next earnings report?
Based on 10
المحللين, MBX Biosciences, Inc. Common Stock is expected to report EPS of -$0.66 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان